Lineage Cell Therapeutics, Inc. Inventory
Lineage Cell Therapeutics, Inc. (LCTX) had Inventory of $1.00 thousand as of 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2016-03-15
- 2015-12-31: Inventory, Net $1.00K.
- 2015-09-30: Inventory, Net $260.00K.
- 2015-06-30: Inventory, Net $297.00K.
- 2015-03-31: Inventory, Net $299.31K.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2015-12-31 | $1.00K 10-K · filed 2016-03-15 | |
| 2015-09-30 | $260.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $297.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $299.31K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $266.00K 10-K · filed 2016-03-15 | $266.02K 10-K · filed 2015-03-11 |
| 2014-09-30 | $253.57K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $257.93K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $236.59K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $178.69K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $61.13K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $64.75K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $52.34K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $55.32K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $56.97K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $55.02K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $54.87K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $51.17K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $61.12K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $56.84K 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $45.47K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |